Web-Books
im Austria-Forum
Austria-Forum
Web-Books
Naturwissenschaften
Chemie
Cancer Nanotheranostics - What Have We Learnd So Far?
Seite - 94 -
  • Benutzer
  • Version
    • Vollversion
    • Textversion
  • Sprache
    • Deutsch
    • English - Englisch

Seite - 94 - in Cancer Nanotheranostics - What Have We Learnd So Far?

Bild der Seite - 94 -

Bild der Seite - 94 - in Cancer Nanotheranostics - What Have We Learnd So Far?

Text der Seite - 94 -

Conniotet al. Nanocarriers for immunecell targetingand tracking Zhang, Q., Zhang, A., Yang, P., and Shen, J. (2013). Synthesis of CdSe quantum dots using various long-chain fatty acids and their phase transfer. J. Nanosci. Nanotechnol.13,4235–4241.:10.1166/jnn.2013.7433 Zhang, Z., Jiang, Q., Jiang, F., Ding, G., Zhang, R., Wang, L., et al. (2004). In vivomagnetic resonance imaging tracks adult neural progenitor cell target- ing of brain tumor.Neuroimage 23, 281–287. doi: 10.1016/j.neuroimage.2004. 05.019 Zhang, Z., Tongchusak, S., Mizukami, Y., Kang, Y. J., Ioji, T., Touma, M., et al. (2011). Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticlemediatedantigendelivery.Biomaterials32,3666–3678.doi: 10.1016/j.biomaterials.2011.01.067 Zhou,Y., Zhang,C., andLiang,W. (2014).Development ofRNAi technology for targetedtherapy-atrackofsiRNAbasedagentstoRNAitherapeutics.J.Control. Release.doi:10.1016/j.jconrel.2014.04.044. [Epubaheadofprint]. Zitvogel, L., Tesniere, A., and Kroemer, G. (2006). Cancer despite immuno- surveillance: immunoselection and immunosubversion.Nat. Rev. Immunol. 6, 715–727.doi:10.1038/nri1936 Zou,W. (2005). Immunosuppressive networks in the tumour environment and their therapeutic relevance.Nat.Rev.Cancer5,263–274.doi:10.1038/nrc1586 Conflict of Interest Statement:The authors declare that the research was con- ducted in the absence of any commercial or financial relationships that could be construedasapotential conflictof interest. Received: 15 September 2014; accepted: 31 October 2014; published online: 26 November2014. Citation: Conniot J, Silva JM, Fernandes JG, Silva LC, Gaspar R, Brocchini S, FlorindoHFandBarataTS(2014)Cancer immunotherapy:nanodeliveryapproaches for immune cell targeting and tracking. Front. Chem. 2:105. doi: 10.3389/fchem. 2014.00105 Thisarticlewas submitted toChemicalEngineering,a sectionof the journalFrontiers inChemistry. Copyright © 2014 Conniot, Silva,Fernandes, Silva,Gaspar,Brocchini,Florindoand Barata. This is an open-access article distributed under the terms of the Creative CommonsAttributionLicense(CCBY).Theuse,distributionorreproductioninother forums is permitted, provided the original author(s) or licensor are credited and that theoriginalpublication in this journal is cited, inaccordancewithacceptedacademic practice.Nouse,distributionorreproduction ispermittedwhichdoesnotcomplywith these terms. www.frontiersin.org November2014 |Volume2 |Article105 | 94
zurück zum  Buch Cancer Nanotheranostics - What Have We Learnd So Far?"
Cancer Nanotheranostics What Have We Learnd So Far?
Titel
Cancer Nanotheranostics
Untertitel
What Have We Learnd So Far?
Autoren
João Conde
Pedro Viana Baptista
Jesús M. De La Fuente
Furong Tian
Herausgeber
Frontiers in Chemistry
Datum
2016
Sprache
englisch
Lizenz
CC BY 4.0
ISBN
978-2-88919-776-7
Abmessungen
21.0 x 27.7 cm
Seiten
132
Schlagwörter
Nanomedicine, Nanoparticles, nanomaterials, Cancer, heranostics, Immunotherapy, bioimaging, Drug delivery, Gene Therapy, Phototherapy
Kategorien
Naturwissenschaften Chemie
Web-Books
Bibliothek
Datenschutz
Impressum
Austria-Forum
Austria-Forum
Web-Books
Cancer Nanotheranostics